Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, provided the Chair's Address and Company Presentation to be presented at the Company's Annual General Meeting.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) released a copy of the presentation to be provided by Dr Richard Lipscombe to attendees of the Bell Potter Healthcare Conference, a virtual event being held 18-20 November 2025.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) announced that its cash reserves have been further strengthened by the receipt of $2.2 million in research and development tax incentive for the 2024-25 financial year.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) announced it has been awarded a $500,000 grant from the Western Australian Government to accelerate the commercialisation of its world-first blood test for endometriosis, a condition affecting one in nine women globally.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) Managing Director Dr. Richard Lipscombe is interviewed about the most recent Quarterly Report and the pipeline of precision diagnostic tests in commercialisation phase.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, announced the following update on its business activities for the three months to 30 September 2025 and subsequent to the period end.
Artificial intelligence is rapidly reshaping how news is distributed and consumed, creating both challenges and opportunities for communicators. That reality took center stage last week at the 2025 Mid-Atlantic MarCom Summit in Arlington, Virginia, where Newsmatics led a discussion on staying visible in an era when AI-driven communications strategies are becoming essential.
